Redhill Biopharma
RDHL
#10477
Rank
โ‚ฌ3.4 M
Marketcap
1,02ย โ‚ฌ
Share price
-0.83%
Change (1 day)
-85.55%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -601,09ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.147ย โ‚ฌ a decrease over its 2016 EPS that were of -1.889ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.147ย โ‚ฌ13.64%
2016-1.889ย โ‚ฌ9.12%
2015-1.731ย โ‚ฌ68.01%
2014-1.030ย โ‚ฌ-25.93%
2013-1.391ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
3,18ย โ‚ฌ-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,52ย โ‚ฌ-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
1,05ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel